Prevalence of sleep-disordered breathing in the general population: the hypnolaus study
Glycemic effectiveness of metformin-based dual-combination therapies with sulphonylurea, pioglitazone, or DPP4-inhibitor in drug-nave Korean type 2 diabetic patients
For Wegovy, NICE guidance (TA875) recommends discontinuation if patients do not achieve at least 5% weight loss after 6 months at the maintenance dose, and NHS treatment is typically limited to a maximum of 2 years
Inflammation peptides target similar pathways through different mechanisms
Common side effects The most common side effects of Foundayo include nausea, constipation, diarrhea, vomiting, indigestion, stomach (abdominal) pain, headache, swollen belly, feeling tired, belching, heartburn, gas, and hair loss